rs200757159
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 8P and 4B. PVS1BS2
The NM_021625.5(TRPV4):c.2198G>A(p.Trp733Ter) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000403 in 1,613,754 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_021625.5 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TRPV4 | NM_021625.5 | c.2198G>A | p.Trp733Ter | stop_gained | 13/16 | ENST00000261740.7 | NP_067638.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TRPV4 | ENST00000261740.7 | c.2198G>A | p.Trp733Ter | stop_gained | 13/16 | 1 | NM_021625.5 | ENSP00000261740 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152244Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000120 AC: 3AN: 249708Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135128
GnomAD4 exome AF: 0.0000431 AC: 63AN: 1461510Hom.: 0 Cov.: 31 AF XY: 0.0000413 AC XY: 30AN XY: 727042
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152244Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74378
ClinVar
Submissions by phenotype
not provided Uncertain:1Other:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Sep 04, 2020 | Not observed in large population cohorts (Lek et al., 2016); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is not a known mechanism of disease; This variant is associated with the following publications: (PMID: 24830047, 25737550, 22851605, 27698146) - |
not provided, no classification provided | literature only | GeneReviews | - | - - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 31, 2020 | The p.W733* variant (also known as c.2198G>A), located in coding exon 12 of the TRPV4 gene, results from a G to A substitution at nucleotide position 2198. This changes the amino acid from a tryptophan to a stop codon within coding exon 12. This variant was detected in the heterozygous state in one individual in an atherosclerosis cohort; however, clinical details were limited (Johnston JJ et al. Am. J. Hum. Genet., 2015 Jun;96:913-25). This variant was also detected in an individual with distal hereditary motor neuropathy (dHMN) and in an unaffected control individual; clinical details were limited (Fawcett KA et al. J. Neurol. Neurosurg. Psychiatry, 2012 Dec;83:1204-9). This alteration is expected to result in premature protein truncation or nonsense-mediated mRNA decay. However, loss of function of TRPV4 has not been clearly established as a mechanism of disease. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Charcot-Marie-Tooth disease axonal type 2C Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 14, 2023 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. ClinVar contains an entry for this variant (Variation ID: 126476). This premature translational stop signal has been observed in individual(s) with clinical features of hereditary motor neuropathy (PMID: 22851605). This variant is present in population databases (rs200757159, gnomAD 0.004%). This sequence change creates a premature translational stop signal (p.Trp733*) in the TRPV4 gene. It is expected to result in an absent or disrupted protein product. However, the current clinical and genetic evidence is not sufficient to establish whether loss-of-function variants in TRPV4 cause disease. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at